indomethacin has been researched along with lysophosphatidylcholines in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (57.14) | 18.7374 |
1990's | 12 (34.29) | 18.2507 |
2000's | 3 (8.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shier, WT | 1 |
Cornaglia-Ferraris, P; Montaldo, PG; Ponzoni, M | 1 |
Hannigan, GE; Williams, BR | 1 |
Fujii, T; Hashizume, T; Kawamoto, A; Sato, T; Tamura, A; Yamaguchi, H | 1 |
Bing, RJ; Menon, NK; Pataricza, J; Zehetgruber, M | 1 |
Daneshmand, H; Dean, P; Deshpande, YG; Kaminski, DL | 1 |
Beinborn, M; Hell, M; Seidler, U; Sewing, KF | 1 |
Daniel, LW; Parker, J; Waite, M | 1 |
Altin, JG; Bygrave, FL; Dieter, P | 1 |
Alves, C; Bing, RJ; Menon, NK; Saeed, M; Saito, T; Wolf, A | 1 |
Bukhave, K; Jivegård, L; Rask-Madsen, J; Svanvik, J; Thornell, E | 1 |
Turinsky, J | 1 |
Lowenstein, LM; Smith, PD; Toback, FG | 1 |
Mizushima, Y; Sakai, S; Yamaura, M | 1 |
Benveniste, J; Hadji, L; Mencia-Huerta, JM | 1 |
Haslam, RJ; Vanderwel, M | 1 |
Kato, R; Nakadate, T; Nakaki, T; Yamamoto, S | 1 |
Ayer, DE; Gorman, RR; Miller, OV | 1 |
Chang, AR; Maclaurin, BP | 1 |
Thornell, E | 1 |
Ferreira, SH; Vargaftig, BB | 1 |
Björck, S; Neiderhiser, D; Svanvik, J; Thornell, E | 1 |
Byers, LW; Chesney, CM; Muirhead, EE; Pifer, DD | 1 |
High, JA; Namm, DH | 1 |
Cox, CP; Farr, RS; Jorgensen, R; Wardlow, ML | 1 |
Fujimoto, R; Hata, F; Kubo, T; Nagao, T; Nishio, H; Takeuchi, T | 1 |
Kugiyama, K; Murohara, T; Ohgushi, M; Ohta, Y; Sugiyama, S; Yasue, H | 1 |
Aoyama, T; Eizawa, H; Hattori, R; Inoue, R; Kosuga, K; Sasayama, S; Yui, Y | 1 |
Clemetson, KJ; Jakubowski, JA; Kramer, RM; Polgár, J; Um, SL | 1 |
Leung, SW; Man, RY; Quan, A; Teoh, H | 1 |
Deng, HW; Li, YJ; Peng, CF; Xiong, XM | 1 |
Trotta, M | 1 |
Cha, YJ; Chang, EA; Kim, CH | 1 |
Fukaya, T; Okatani, Y; Taniguchi, K; Wakatsuki, A; Watanabe, K | 1 |
Kamata, K; Kobayashi, T; Matsumoto, T; Miyamori, K | 1 |
1 trial(s) available for indomethacin and lysophosphatidylcholines
Article | Year |
---|---|
Mechanisms in the development of acute cholecystitis and biliary pain. A study on the role of prostaglandins and effects of indomethacin.
Topics: Acute Disease; Animals; Biliary Tract; Cats; Cholecystitis; Cholelithiasis; Clinical Trials as Topic; Dinoprostone; Double-Blind Method; Female; Gallbladder; Humans; Indomethacin; Lysophosphatidylcholines; Male; Pain; Pressure; Prostaglandin Antagonists; Prostaglandins; Prostaglandins E | 1982 |
34 other study(ies) available for indomethacin and lysophosphatidylcholines
Article | Year |
---|---|
Inhibition of prostaglandin synthesis by lysolecithin.
Topics: Animals; Arachidonic Acids; Cattle; Cell Line; Indomethacin; Kinetics; Lysophosphatidylcholines; Male; Microsomes; Prostaglandins E; Seminal Vesicles; Structure-Activity Relationship | 1977 |
Stimulation of receptor-coupled phospholipase A2 by interferon-gamma.
Topics: Arachidonic Acid; Chromatography, Thin Layer; Enzyme Activation; Humans; Indomethacin; Interferon-gamma; Lysophosphatidylcholines; Masoprocol; Neuroblastoma; Phospholipases A; Phospholipases A2; Signal Transduction; Tumor Cells, Cultured | 1992 |
Signal transduction by interferon-alpha through arachidonic acid metabolism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetophenones; Animals; Arachidonic Acid; Arachidonic Acids; Base Sequence; Cell Line; Cyclooxygenase Inhibitors; Enhancer Elements, Genetic; Enzyme Activation; Indomethacin; Interferon Type I; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Masoprocol; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Phospholipases A; Phospholipases A2; Platelet-Derived Growth Factor; Second Messenger Systems; Signal Transduction; Transcription Factors; Transcription, Genetic; Transfection | 1991 |
Lipid peroxide makes rabbit platelet hyperaggregable to agonists through phospholipase A2 activation.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Enzyme Activation; Ferrous Compounds; Indomethacin; Lipid Peroxidation; Lysophosphatidylcholines; Peroxides; Phospholipases A; Phospholipases A2; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Quinacrine; Rabbits; tert-Butylhydroperoxide; Vitamin E | 1991 |
A model to study physiological activation of phospholipase A2 and vasorelaxation by lysophosphatidylcholine.
Topics: Acetylcholine; Animals; Bradykinin; Calcimycin; Carbon Radioisotopes; Cattle; Endothelium; Enzyme Activation; Histamine; Indomethacin; Lipid Metabolism; Lysophosphatidylcholines; Muscle Relaxation; Muscle, Smooth, Vascular; Phenylephrine; Phosphatidylcholines; Phospholipases A; Phospholipases A2; Pulmonary Artery; Thrombin | 1990 |
Prostanoids and leukotrienes in experimental feline cholecystitis.
Topics: Animals; Calcium; Cats; Cholecystitis; Indomethacin; Ionophores; Leukotrienes; Lysophosphatidylcholines; Osmolar Concentration; Prostaglandins | 1990 |
Up-regulation of prostaglandin E2 binding and of prostanoid release in rabbits producing antibodies against prostaglandin E2.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antibody Formation; Arachidonic Acids; Dinoprostone; Epoprostenol; Gastric Acid; Gastric Mucosa; Indomethacin; Lysophosphatidylcholines; Male; Parietal Cells, Gastric; Phospholipases A; Phospholipases A2; Rabbits; Receptors, Prostaglandin; Stomach Ulcer | 1989 |
Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Dogs; Dose-Response Relationship, Drug; Enzyme Activation; Indomethacin; Isoquinolines; Kidney; Lysophosphatidylcholines; Molecular Weight; Phospholipid Ethers; Phosphorylation; Piperazines; Prostaglandins; Protein Kinase C; Tetradecanoylphorbol Acetate | 1987 |
Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathwa
Topics: Acetophenones; Animals; Calcium; Dose-Response Relationship, Drug; Indomethacin; Liver; Liver Glycogen; Lysophosphatidylcholines; Male; Oxygen Consumption; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains | 1987 |
Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide)
Topics: Acetylcholine; Animals; Biological Factors; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemoglobins; Indomethacin; Lysophosphatidylcholines; Male; Masoprocol; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Rabbits | 1988 |
Prostaglandin E2 formation by the gall bladder in experimental cholecystitis.
Topics: Animals; Cats; Cholecystitis; Dilatation; Dinoprostone; Female; Gallbladder; Indomethacin; Lysophosphatidylcholines; Male; Prostaglandins E | 1986 |
Phospholipids, prostaglandin E2, and proteolysis in denervated muscle.
Topics: Animals; Aspirin; Cardiolipins; Cycloheximide; Dinoprostone; Indomethacin; Lysophosphatidylcholines; Male; Muscle Denervation; Muscle Proteins; Muscles; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Prostaglandins E; Rats; Rats, Inbred Strains; Sphingomyelins; Tyrosine | 1986 |
Phospholipid metabolism in the initiation of renal compensatory growth after acute reduction of renal mass.
Topics: Animals; Carbon Radioisotopes; Cell Membrane; Choline; Indomethacin; Kidney; Kidney Cortex; Lysophosphatidylcholines; Male; Mice; Nephrectomy; Phosphatidylcholines; Phospholipids; Rats; Sphingomyelins | 1974 |
Mode of stabilizing action of non-steroid anti-inflammatory drugs on erythrocyte membrane.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Cell Membrane; Dogs; Erythrocytes; Flufenamic Acid; Hemolysis; Hot Temperature; Hydrogen-Ion Concentration; Indomethacin; Lysophosphatidylcholines; Nitrobenzenes; ortho-Aminobenzoates; Oxyphenbutazone; Phenylbutazone; Phospholipases; Protein Denaturation; Pyrazoles; Salicylates; Saponins; Serum Albumin, Bovine; Sulfates; Surface-Active Agents | 1970 |
Release of a slow-reacting substance from rabbit platelets.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenosine Diphosphate; Animals; Arachidonic Acids; Aspirin; Autacoids; Blood Platelets; Chromatography, High Pressure Liquid; Cysteine; Indomethacin; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1981 |
Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Creatine Kinase; Cyclic AMP; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Prostaglandins E; Rabbits | 1982 |
Possible involvement of phospholipase A2 activation and lipoxygenase product(s) in the mechanism of insulin secretion.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arginine; Enzyme Activation; Glucose; Glyburide; In Vitro Techniques; Indomethacin; Insulin; Insulin Secretion; Islets of Langerhans; Lipoxygenase; Lysophosphatidylcholines; Male; Phospholipases; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Strains | 1983 |
Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Topics: Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Epoprostenol; Humans; Indomethacin; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1982 |
Rapid induction of gastric ulceration in guinea pigs by sequential exposure to a barrier breaker and indomethacin.
Topics: Animals; Bile; Gastric Mucosa; Guinea Pigs; Indomethacin; Lysophosphatidylcholines; Stomach Ulcer; Taurocholic Acid | 1983 |
Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors.
Topics: Animals; Aspirin; Carrageenan; Cyclooxygenase Inhibitors; Edema; Hyperalgesia; Indomethacin; Lysophosphatidylcholines; Platelet Activating Factor; Rats | 1981 |
The effect of lysophosphatidylcholine on gallbladder function in the cat.
Topics: Animals; Bile; Blood Proteins; Cats; Female; Gallbladder; Hexosamines; Indomethacin; Lysophosphatidylcholines; Male; Muscle Contraction; Perfusion; Proteins | 1983 |
Effect of platelet-activating factor (PAF) on human platelets.
Topics: Animals; Antimycin A; Aspirin; Blood Platelets; Cattle; Creatine Kinase; Deoxyglucose; Epoprostenol; Humans; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin | 1982 |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity.
Topics: Adenosine Diphosphate; Animals; Apyrase; Arachidonic Acids; Blood Platelets; Cattle; Indomethacin; Lipids; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1980 |
The presence of platelet-activating factor (PAF) in normal human mixed saliva.
Topics: Adenosine Diphosphate; Adult; Animals; Arachidonic Acids; Creatine Kinase; Dose-Response Relationship, Immunologic; Female; Hirudins; Humans; Indomethacin; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Rabbits; Saliva; Serotonin; Thrombin | 1981 |
Ca(2+)-independent fusion of secretory granules with phospholipase A2-treated plasma membranes in vitro.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Albumins; Amylases; Animals; Arachidonic Acid; Benzoquinones; Calcium; Cell Membrane; Cytoplasmic Granules; Egtazic Acid; Exocytosis; Fatty Acids; Indomethacin; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Male; Membrane Fusion; Microscopy, Electron; Parotid Gland; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Wistar | 1995 |
LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Topics: Animals; Arginine; Copper; Coronary Vessels; Dinoprost; Endothelium, Vascular; Humans; Indomethacin; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Nitroglycerin; omega-N-Methylarginine; Oxidation-Reduction; Superoxide Dismutase; Swine; Thrombin; Vasoconstriction; Vasodilation | 1994 |
Lysophosphatidylcholine inhibits endothelium-dependent hyperpolarization and N omega-nitro-L-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery.
Topics: Animals; Arginine; Biological Factors; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Indomethacin; Lysophosphatidylcholines; Membrane Potentials; Nitric Oxide Synthase; Nitroarginine; Swine | 1995 |
Human group II 14 kDa phospholipase A2 activates human platelets.
Topics: Arachidonic Acid; Blood Platelets; Calcium; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Humans; Indoles; Indomethacin; Lysophosphatidylcholines; Magnesium; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoinositide Phospholipase C; Phospholipases A; Phospholipases A2; Phosphorylation; Phosphotyrosine; Platelet Activation; Platelet Aggregation; Polysaccharide-Lyases; Recombinant Proteins; Thromboxane A2; Type C Phospholipases | 1997 |
Endothelial dysfunction exacerbates the impairment of relaxation by lysophosphatidylcholine in porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Indomethacin; Lysophosphatidylcholines; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ouabain; Swine; Vasoconstrictor Agents | 1997 |
Protective effects of 17 beta-estradiol on endothelial function injured by oxidized low-density lipoproteins.
Topics: Animals; Aorta, Thoracic; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; In Vitro Techniques; Indomethacin; Lipoproteins, HDL; Lysophosphatidylcholines; Male; Rabbits; Vasodilation | 1996 |
Influence of phase transformation on indomethacin release from microemulsions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crystallization; Delayed-Action Preparations; Drug Delivery Systems; Emulsions; Ethanol; Hydrogen-Ion Concentration; In Vitro Techniques; Indomethacin; Lysophosphatidylcholines; Myristates; Particle Size; Phosphatidylcholines; Solvents; Time Factors; Water | 1999 |
Effects of endothelial cells and mononuclear leukocytes on platelet aggregation.
Topics: Animals; Blood Platelets; Cell Communication; Coculture Techniques; Collagen; Endothelium, Vascular; Humans; Indomethacin; Leukocytes, Mononuclear; Lipoproteins, LDL; Lysophosphatidylcholines; omega-N-Methylarginine; Oxidation-Reduction; Platelet Aggregation; Platelet Function Tests; Swine; Time Factors | 2000 |
Melatonin suppresses lysophosphatidylcholine enhancement of serotonin-induced vasoconstriction in the human umbilical artery.
Topics: Adult; Dose-Response Relationship, Drug; Drug Synergism; Female; Free Radical Scavengers; Humans; Indomethacin; Lysophosphatidylcholines; Mannitol; Melatonin; Muscle, Smooth, Vascular; omega-N-Methylarginine; Pregnancy; Serotonin; Umbilical Arteries; Vasoconstriction | 2000 |
Specific impairment of endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from streptozotocin-induced diabetic mice.
Topics: Acetylcholine; Animals; Biological Factors; Connexins; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gap Junction alpha-4 Protein; Gap Junction alpha-5 Protein; Gene Expression Regulation; Indomethacin; Lysophosphatidylcholines; Male; Mesenteric Arteries; Mice; Nitroarginine; Nitroprusside; Potassium Channels, Calcium-Activated; RNA, Messenger; Streptozocin; Vasodilation; Vasodilator Agents | 2006 |